Guardant Health
GH
#1531
Rank
ยฃ10.15 B
Marketcap
ยฃ78.20
Share price
2.11%
Change (1 day)
174.11%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Total debt

Total debt on the balance sheet as of September 2025 : ยฃ0.99 Billion

According to Guardant Health 's latest financial reports the company's total debt is ยฃ0.99 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Guardant Health - Total debt on balance sheet (from 2017 to 2025)

Total debt by year

Year Total debt Change
2024-12-31ยฃ1.06 B0.19%
2023-12-31ยฃ1.06 B-6.12%
2022-12-31ยฃ1.13 B11.21%
2021-12-31ยฃ1.01 B62.34%
2020-12-31ยฃ0.62 B1934.95%
2019-12-31ยฃ30.8 M
2018-12-31N/A-100%
2017-12-31ยฃ0.48 M-96.47%
2016-12-31ยฃ13.8 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Natera
NTRA
ยฃ0.14 B-85.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Neogen
NEOG
ยฃ0.59 B-40.25%๐Ÿ‡บ๐Ÿ‡ธ USA